ketoprofen has been researched along with substance p in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Gerstenberg, T; Hald, T; Klarskov, P | 1 |
Bestetti, A; Clavenna, G; Daffonchio, L; Fedele, G; Ferrari, MP; Omini, C | 1 |
Desai, PR; Shah, PP; Singh, M | 1 |
Channer, D; Desai, PR; Shah, PP; Singh, M | 1 |
Feist, M; Knubben-Schweizer, G; Tschoner, TS; Zablotski, Y | 1 |
1 trial(s) available for ketoprofen and substance p
Article | Year |
---|---|
Effect of xylazine administration before laparoscopic abomasopexy to correct left displaced abomasum on markers of stress in dairy cows.
Topics: Abomasum; Animals; Cattle; Cattle Diseases; Digestive System Surgical Procedures; Female; Germany; Hydrocortisone; Hypnotics and Sedatives; Ketoprofen; Laparoscopy; Perioperative Care; Stomach Diseases; Substance P; Xylazine | 2020 |
4 other study(ies) available for ketoprofen and substance p
Article | Year |
---|---|
Vasoactive intestinal polypeptide influence on lower urinary tract smooth muscle from human and pig.
Topics: Animals; Carbachol; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Ketoprofen; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Propranolol; Prostaglandins E; Prostaglandins F; Substance P; Swine; Tetrodotoxin; Urethra; Urinary Bladder; Vasoactive Intestinal Peptide | 1984 |
Effects of a new foam formulation of ketoprofen lysine salt in experimental models of inflammation and hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Diclofenac; Exudates and Transudates; Female; Gastric Mucosa; Gels; Hyperalgesia; Inflammation; Ketoprofen; Lysine; Male; Prostaglandins; Rats; Rats, Sprague-Dawley; Substance P | 1995 |
Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.
Topics: Administration, Cutaneous; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Humans; Ketoprofen; Lactic Acid; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Oleic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Skin; Skin Absorption; Substance P; Succinimides | 2012 |
Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
Topics: Administration, Topical; Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell-Penetrating Peptides; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Drug Carriers; Ketoprofen; Lipids; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Oligopeptides; Peptides; Rats; Rats, Hairless; Skin Absorption; Substance P | 2012 |